This prospective randomized trial will compare outcomes in patients receiving aspirin in combination with a low-molecular weight heparin and those under this center's standard protocol receiving neither medication, in order to determine if these medications may improve success rates.
This prospective randomized trial will compare outcomes in patients receiving aspirin (81mg daily) in combination with a low-molecular weight heparin (LMWH) (enoxaparin (Lovenox®), 40mg daily subcutaneous injection) and those under this center's standard protocol receiving neither medication, in order to determine if these medications may improve success rates.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
130
A low-molecular-weight heparin, 40mg daily injection.
Aspirin 81mg daily tablet.
Embryo transfer
Fertility center of Las Vegas
Las Vegas, Nevada, United States
RECRUITINGSerum hCG level
Serum hCG level
Time frame: 5 days post transfer
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.